Evidence map›Paper›PMID 20411258›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2010

Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.

Arthur J H A Scholte, Joanne D Schuijf, Victoria Delgado, Jurriaan A Kok, Mieke T J Bus, Arie C Maan, Marcel P Stokkel, Antje V Kharagitsingh, Petra Dibbets-Schneider, Ernst E van der Wall and 1 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Mercury Exposure and Heart Rate Variability: a Systematic Review.Current environmental health reports · 2015
    Pooled it
  2. Trial
  3. [Diagnostics (Basel, Switzerland) · 2025
    Article
  4. Thyroid [IBRO neuroscience reports · 2023
    Article
  5. Article
  6. Cardiac sympathetic dysfunction in left ventricular hypertrophy caused by arterial hypertension and degenerative aortic stenosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  7. Review
  8. Current View of Diagnosing Small Fiber Neuropathy.Journal of neuromuscular diseases · 2021
    Review
  9. Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  10. Article
  11. Review
  12. Thyroid MIBG uptake in Parkinson's disease with diabetes mellitus.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2013
    Article
  13. Article
  14. Article
  15. Article
  16. Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2012
    Article
  17. Cardiac sympathetic imaging with mIBG: a tool for better assessment of the diabetic heart.European journal of nuclear medicine and molecular imaging · 2010
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Arthur J H A ScholteDepartment of Cardiology, Leiden University Medical Center, Leiden, the Netherlands. a.j.h.a.scholte@lumc.nl
Joanne D Schuijf
Victoria Delgado
Jurriaan A Kok
Mieke T J Bus
Arie C Maan
Marcel P Stokkel
Antje V Kharagitsingh
Petra Dibbets-Schneider
Ernst E van der Wall
Jeroen J Bax
Leiden University Medical Center · NLMedisch Centrum Haaglanden · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to evaluate the prevalence of cardiac autonomic neuropathy (CAN) in a cohort of patients with type 2 diabetes, truly asymptomatic for coronary artery disease (CAD), using heart rate variability (HRV) and (123)I-metaiodobenzylguanidine ((123)I-mIBG) myocardial scintigraphy.

methodsThe study group comprised 88 patients with type 2 diabetes prospectively recruited from an outpatient diabetes clinic. In all patients myocardial perfusion scintigraphy, CAN by HRV and (123)I-mIBG myocardial scintigraphy were performed. Two or more abnormal tests were defined as CAN-positive (ECG-based CAN) and one or fewer as CAN-negative. CAN assessed by (123)I-mIBG scintigraphy was defined as abnormal if the heart-to-mediastinum ratio was <1.8, the washout rate was >25%, or the total defect score was >13.

resultsThe prevalence of CAN in patients asymptomatic for CAD with type 2 diabetes and normal myocardial perfusion assessed by HRV and (123)I-mIBG scintigraphy was respectively, 27% and 58%. Furthermore, in almost half of patients with normal HRV, (123)I-mIBG scintigraphy showed CAN.

conclusionThe current study revealed a high prevalence of CAN in patients with type 2 diabetes. Secondly, disagreement between HRV and (123)I-mIBG scintigraphy for the assessment of CAN was observed.

Indexed as

3-IodobenzylguanidineHeart RateAutonomic Nervous SystemDiabetes Mellitus, Type 2Diabetic CardiomyopathiesDiabetic NeuropathiesFemaleHeartHumansMaleMiddle AgedMyocardial Perfusion ImagingTomography, Emission-Computed, Single-Photon3-Iodobenzylguanidine

Identifiers

PMID20411258
PMCPMC2918794
OpenAlexW2078377274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.